G0475 HCPCS Level II Code: Hiv antigen/antibody, combination assay, screening
Medicare Coverage & Payment
- CMS short descriptor: Hiv combination assay
- Medicare coverage: Carrier judgment (CMS coverage code C)
- Pricing indicator: 13
- BETOS: T2D — Other tests - other
- Last CMS action effective: April 13, 2015
Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.
Contextual Map
Every relationship of G0475 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
Nearest codes (40)
- G0451 — Development testing, with interpretation and report, per standardized instrument form[Sibling]
- G0452 — Molecular pathology procedure; physician interpretation and report[Sibling]
- G0453 — Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure)[Sibling]
- G0454 — Physician documentation of face-to-face visit for durable medical equipment determination performed by nurse practitioner, physician assistant or clinical nurse specialist[Sibling]
- G0455 — Preparation with instillation of fecal microbiota by any method, including assessment of donor specimen[Sibling]
- G0456 — Negative pressure wound therapy, (e.g. vacuum assisted drainage collection) using a mechanically-powered device, not durable medical equipment, including provision of cartridge and dressing(s), topical application(s), wound assessment, and instructions for ongoing care, per session; total wounds(s) surface area less than or equal to 50 square centimeters[Sibling]
- G0457 — Negative pressure wound therapy, (e.g. vacuum assisted drainage collection) using a mechanically-powered device, not durable medical equipment, including provision of cartridge and dressing(s), topical application(s), wound assessment, and instructions for ongoing care, per session; total wounds(s) surface area greater than 50 square centimeters[Sibling]
- G0458 — Low dose rate (ldr) prostate brachytherapy services, composite rate[Sibling]
- and 32 more
Change history
- April 13, 2015 — Added to the code set [Change history]
Sources for this page
Every coding fact on this page is read from the datasets below. Nothing is AI-generated; MedCoder-derived relationships and editorial are labelled where they appear.
- Code, descriptors, coverage and pricing attributes
- CMS HCPCS Alpha-Numeric (ANWEB) release — July 2026 quarterly update
- Change history and date-of-service validity
- CMS HCPCS quarterly update files, ingested into the change ledger
- Comparisons, relationships and the contextual map MedCoder-derived
- Derived by MedCoder from the tabular notes and tables above; every derived relationship is marked as derived where it appears
Change history
- April 13, 2015Added to the code setHiv antigen/antibody, combination assay, screening
Nearest Codes in This Family
Official HCPCS Level II classifications closest to G0475 in its code family, with their registry titles.
- G0469 — Federally qualified health center (fqhc) visit, mental health, new patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between a new patient and a fqhc practitioner…
- G0470 — Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc…
- G0471 — Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha)
- G0472 — Hepatitis c antibody screening, for individual at high risk and other covered indication(s)
- G0473 — Face-to-face behavioral counseling for obesity, group (2-10), 30 minutes
- G0476 — Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be…
- G0477 — Drug test(s), presumptive, any number of drug classes; any number of devices or procedures, (e.g., immunoassay) capable of being read by direct optical observation only (e.g., dipsticks, cups, cards,…
- G0478 — Drug test(s), presumptive, any number of drug classes; any number of devices or procedures, (e.g., immunoassay) read by instrument-assisted direct optical observation (e.g., dipsticks, cups, cards,…
- G0479 — Drug test(s), presumptive, any number of drug classes; any number of devices or procedures by instrumented chemistry analyzers utilizing immunoassay, enzyme assay, tof, maldi, ldtd, desi, dart, ghpc,…
- G0480 — Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but…